MRI of the pancreas for cancer screening
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study uses MRI scans to screen for pancreas cancer in people at high risk due to family history or certain gene mutations. It aims to see if MRI can help find cancer early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 21 or older and at high risk for pancreas cancer because of your family history or a gene mutation.
- You must have had at least one pancreas MRI in the last 3 years without any concerning findings.
- You must be scheduled for an endoscopic ultrasound (a procedure that uses a sound wave tube to look at the pancreas) on the same day as the MRI.
- You cannot have claustrophobia (fear of tight spaces) or have needed medicine to relax during a previous MRI.
- You must not have any medical condition that raises the risk of anesthesia or have had abdominal surgery that could affect the tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether regular imaging can find pancreatic cancer earlier in people who recently developed diabetes or whose diabetes is getting worse. It may help detect pancreatic problems sooner when treatment options are likely better.
This Phase 3 study tests a structured plan for checking the pancreas early in people with a higher-than-usual risk of pancreatic cancer. The goal is to find changes sooner, when treatment may be easier.
This trial tests ways to screen people who have a family-passed (inherited) gene mutation linked to higher pancreatic cancer risk. The goal is to find pancreatic cancer earlier and improve how screening is done for people at increased risk.
This trial studies whether adding an MRI scan improves the selection of people with pancreatic cancer who may benefit from surgery. It focuses on patients without liver spread and with tumors that are borderline or likely removable.
This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.
This study tests a new, harmless “disposable” setup for MRI scans to measure how pancreatic cancer treatments affect the body. It may help doctors get more accurate MRI measurements, so treatment response can be assessed better.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.